Back to top
more

Becton, Dickinson and Company (BDX)

(Real Time Quote from BATS)

$234.27 USD

234.27
945,204

+2.63 (1.14%)

Updated Nov 11, 2024 03:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (88 out of 250)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

The Zacks Analyst Blog Highlights: Abbott Lab, Quidel, Becton, Dickinson and Company, Hologic and Quest Diagnostics

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Abbott Lab, Quidel, Becton, Dickinson and Company, Hologic and Quest Diagnostics

Urmimala Biswas headshot

Price War in Coronavirus Test Space to Intensify Thanks to Abbott

by Urmimala Biswas

Most rapid antigen tests in the United States require an additional system, which is making the procedures more costly and complex.

Company News for Aug 7, 2020

by Zacks Equity Research

Companies In The News: BMY, CRON, BDX, LNG.

Becton Dickinson (BDX) Earnings Surpass Estimates in Q3

by Zacks Equity Research

Within the United States, Becton Dickinson's (BDX) Diagnostic Systems unit witnessed strong revenue growth in Q3.

Becton Dickinson (BDX) Q3 Earnings Beat Estimates

by Zacks Equity Research

Becton Dickinson (BDX) delivered earnings and revenue surprises of 7.32% and -1.88%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Why Becton, Dickinson (BDX) Might Surprise This Earnings Season

by Zacks Equity Research

Becton, Dickinson (BDX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

What's in Store for Becton, Dickinson's (BDX) Q3 Earnings?

by Zacks Equity Research

Becton, Dickinson's (BDX) fiscal third-quarter results likely to reflect robust performance at BD Life Sciences. However, forex is likely to have remained a woe.

Becton Dickinson (BDX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

Becton Dickinson (BDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Becton Dickinson (BDX) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

BD Collaborates With BARDA to Combat Coronavirus Crisis

by Zacks Equity Research

Becton, Dickinson (BDX) forms a strategic public-private partnership with BARDA to help the U.S. government in its efforts to fight the COVID-19 pandemic and future pandemics.

BD Receives EUA for New Antigen Test to Combat COVID-19

by Zacks Equity Research

Becton, Dickinson (BDX) receives EUA from the FDA for a rapid, point-of-care, antigen test to detect SARS-CoV-2 in 15 minutes.

BD Unveils BD PurPrep Patient Preoperative Skin Preparation

by Zacks Equity Research

By developing fully sterile PurPrep, BD (BDX) is offering health care experts a more complete set of tools to mitigate the risk of intrinsic contamination in antiseptic solutions.

Trina Mukherjee headshot

Near-Term Outlook Bleak for Medical Dental Supplies Industry

by Trina Mukherjee

Digital influence coupled with AI & Robotics can drive the medical dental supplies industry amid the coronavirus-induced crisis.

Why Is Becton Dickinson (BDX) Down 5.6% Since Last Earnings Report?

by Zacks Equity Research

Becton Dickinson (BDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Becton Dickinson (BDX) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

Becton Dickinson's (BDX) second-quarter results reflect solid performance by the core Life Sciences and Interventional segments.

Becton Dickinson (BDX) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Becton Dickinson (BDX) delivered earnings and revenue surprises of 11.84% and 3.43%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Trina Mukherjee headshot

Medical Products Stock Earnings on May 7: BDX, ABC & More

by Trina Mukherjee

Medical Product companies have partially mitigated the impact of the pandemic with the massive adoption of COVID-19 related healthcare-support products and services.

What's in Store for Becton, Dickinson's (BDX) Q2 Earnings?

by Zacks Equity Research

Becton, Dickinson's (BDX) fiscal second-quarter results likely to reflect robust performance at BD Life Sciences. However, forex is likely to have remained a woe.

Analysts Estimate Becton Dickinson (BDX) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Becton Dickinson (BDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Sheraz Mian headshot

Q1 Earnings Scorecard and Analyst Reports for Exxon, Oracle & Eli Lilly

by Sheraz Mian

In addition to the Q1 earnings scorecard, today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil (XOM), Oracle (ORCL) and Eli Lilly (LLY).

BD (BDX) Receives EUA for New Coronavirus Detection Test

by Zacks Equity Research

Becton, Dickinson (BDX) receives EUA from the FDA for another molecular diagnostic test for COVID-19, which can return results in two to three hours.

Sweta Jaiswal, FRM headshot

Healthcare Stocks & ETFs to Gain on Coronavirus Test Progress

by Sweta Jaiswal, FRM

It seems that testing for COVID-19 is the major key in controlling the outbreak and helps in making decisions like treatment protocols, resource allocation and drafting the right healthcare policies.

BD Gets EUA for New Test to Combat the Coronavirus Crisis

by Zacks Equity Research

BD (BDX) partners with BioGX to introduce a new diagnostic test to help hospitals boost the capacity of quick, on-site testing of COVID-19.

BD Launches New Test to Help Combat the Coronavirus Outbreak

by Zacks Equity Research

BD (BDX), along with BioMedomics, launches a new point-of-care test to help fight the coronavirus outbreak.

Luminex (LMNX) Receives EUA for Coronavirus Detection Test

by Zacks Equity Research

Luminex (LMNX) receives EUA for its NxTAG CoV Extended Panel that will be used to detect the SARS-CoV-2 virus.